Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway

Daiju TAO; Peng CHEN; Yuqing LI; Linyi CHEN; Renhua YANG; Bo HE; Zhiqiang SHEN

doi:10.12259/j.issn.2095-610X.S20231019

Volume 44 Issue 10

Oct. 2023

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2023 > 44(10): 18-25

Daiju TAO, Peng CHEN, Yuqing LI, Linyi CHEN, Renhua YANG, Bo HE, Zhiqiang SHEN. Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway[J]. Journal of Kunming Medical University, 2023, 44(10): 18-25. doi: 10.12259/j.issn.2095-610X.S20231019

Citation:

Daiju TAO, Peng CHEN, Yuqing LI, Linyi CHEN, Renhua YANG, Bo HE, Zhiqiang SHEN. Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway[J]. Journal of Kunming Medical University, 2023, 44(10): 18-25. doi: 10.12259/j.issn.2095-610X.S20231019

Citation:

Daiju TAO, Peng CHEN, Yuqing LI, Linyi CHEN, Renhua YANG, Bo HE, Zhiqiang SHEN. Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway[J]. Journal of Kunming Medical University, 2023, 44(10): 18-25. doi: 10.12259/j.issn.2095-610X.S20231019

PDF( 2904 KB)

Protective Effect of Corilagin on OX-LDL-Induced HUVECs Cell Damage and Its Impact on the Expression of the MyD88 Signaling Pathway

doi: 10.12259/j.issn.2095-610X.S20231019

School of Pharmaceutical Science/Yunnan Key Laboratory of Pharmacology for Natural Products，Kunming Medical University，Kunming Yunnan 650500，China

Received Date: 2023-05-31
Available Online: 2023-09-07
Publish Date: 2023-10-25

Abstract

Abstract

Objective To investigate the protective effects of different concentrations and durations of corilagin treatment on oxidative low-density lipoprotein （ox-LDL）-induced damage in human umbilical vein endothelial cells （HUVECs）, as well as its effects on the expression regulation of the MyD88 signaling pathway. Methods In vitro cultured HUVECs were used to replicate the ox-LDL-induced damage model. Morphological and immunological methods were employed to identify HUVECs cells. The MTT assay was used to determine the optimal conditions for replicating the ox-LDL-induced damage model in HUVECs. Cells were divided into different groups based on different treatments: normal group, model group, Corilagin （3.125, 6.25, 12.5, 25, 50 µmol/L） group, and positive control （VE 10 µmol/L, Simvastatin 1 µmol/L） group. The protective effect of corilagin on ox-LDL-induced damage in HUVECs was observed. Western blot and RT-qPCR methods were used to detect the expression changes of MyD88, P65, TNF-α, and MCP-1 in HUVECs cells. Results The cultured cells were confirmed as HUVECs by using morphological and immunological methods. The best condition for replicating ox-LDL-induced damage to HUVECs was 12 hours of treatment with 70 mg/L of ox-LDL. MTT results showed that compared with the ox-LDL group, the corilagin group had a significantly higher cell viability （P < 0.01）. RT-qPCR and Western blot results showed that compared with the control group, the mRNA and protein expression of MyD88, P65, TNF-α, and MCP-1 were increased in the ox-LDL group （P < 0.01）. Compared with the ox-LDL group, the mRNA and protein expression of MyD88, P65, TNF-α, and MCP-1 were decreased （P < 0.01） in the corilagin group and positive control group, and the corilagin group showed a dose-dependent downregulation of the mRNA and protein expression of MyD88, P65, TNF-α, and MCP-1. Conclusion With the increase of time and concentration, corilagin can significantly improve the cell viability of HUVECs induced by ox-LDL damage, and its protective effect is associated with the inhibition of the MyD88 signaling pathway.
- Corilagin,
- HUVECs,
- Ox-LDL,
- Atherosclerosis

FullText(HTML)

References(15)

References

[1]	Shah P K. Inflammation,infection and atherosclerosis[J]. Trends Cardiovas Med,2019,29(8):468-472. doi: 10.1016/j.tcm.2019.01.004
[2]	Sharma T,Romeo F,Mehta J L. LOX-1: Implications in atherosclerosis and myocardial ischemia[J]. Excli J,2022,21(1):273-278.
[3]	Gao W,Liu H,Yuan J,et al. Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway[J]. J Cell Mol Med,2016,20(12):2318-2327. doi: 10.1111/jcmm.12923
[4]	Xiong X,Lu W,Zhang K,et al. Pterostilbene reduces endothelial cell apoptosis by regulation of the Nrf2-mediated TLR-4/MyD88/NF-κB pathway in a rat model of atherosclerosis[J]. Exp Ther Med,2020,20(3):2090-2098.
[5]	Chen T,Luo W,Wu G,et al. A novel MyD88 inhibitor LM9 prevents atherosclerosis by regulating inflammatory responses and oxidative stress in macrophages[J]. Toxicol Appl Pharm,2019,370(1):44-55.
[6]	Hosseini H,Li Y,Kanellakis P,et al. Toll-like receptor (TLR)4 and MyD88 are essential for atheroprotection by peritoneal B1a B cells[J]. J Am Heart Assoc,2016,5(11):e002947. doi: 10.1161/JAHA.115.002947
[7]	Basurto L,Gregory M A,Hernández S B,et al. Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women[J]. Exp Gerontol,2019,124(1):110624-110631.
[8]	Yu H,Cao H,Yu H. MicroRNA-98 inhibition accelerates the development of atherosclerosis via regulation of dysfunction of endothelial cell[J]. Clin Exp Hypertens,2023,45(1):2206068. doi: 10.1080/10641963.2023.2206068
[9]	夏欣,杨媛,李发靖,等. 柯里拉京的心脑血管保护作用及机制研究进展[J]. 医学综述,2022,28(2):229-234.
[10]	Tao Y,Zhang L,Yang R,et al. Corilagin ameliorates atherosclerosis by regulating MMP-1,-2,and -9 expression in vitro and in vivo[J]. Eur J Pharmacol,2021,906(1):174200-174210.
[11]	郭英,陈鹏,谢建平,等. Corilagin对血管内皮细胞的保护作用及LOX-1蛋白表达的影响[J]. 中成药,2012,34(1):151-154.
[12]	郭英,陈鹏,谢建平,等. Corilagin对HUVEC的保护作用及LOX-1 mRNA表达的影响[J]. 时珍国医国药,2011,22(10):2419-2421. doi: 10.3969/j.issn.1008-0805.2011.10.044
[13]	Gunta S P,O'keefe J H,O'keefe E L,et al. PCSK9 inhibitor,ezetimibe,and bempedoic acid: Evidence-based therapies for statin-intolerant patients[J]. Prog Cardiovasc Dis,2023,13(5):e068915.
[14]	Zhu K,Wang X,Weng Y,et al. Sulfated galactofucan from sargassum thunbergii attenuates atherosclerosis by suppressing inflammation via the TLR4/MyD88/NF-κB signaling pathway[J]. Cardiovasc Drug Ther,2022,10(1):7383-7397.
[15]	Park H J,Zhang Y,Georgescu S P,et al. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis[J]. Stem Cell Rev,2006,2(2):93-102. doi: 10.1007/s12015-006-0015-x

Relative Articles(20)

Relative Articles

[1]	Yi YANG, Shen SHEN, Mengxia WAN, Yongbo ZHANG. Preoperative Fasting Triglyceride-glucose Index as a Predictor of Contralateral New Silent Ischemic Brain Lesions after Carotid Artery Stenting. Journal of Kunming Medical University, 2025, 46(2): 74-79. doi: 10.12259/j.issn.2095-610X.S20250211
[2]	Aiyun WANG, Yuting WANG, Jing CAI, Ruoyan NI, Caiying LUO, Zhuo YU, Peng CHEN. The Role of Intestinal Flora and Its Metabolites in The Development of Atherosclerosis. Journal of Kunming Medical University, 2024, 45(12): 160-166. doi: 10.12259/j.issn.2095-610X.S20241223
[3]	Li ZHANG, Yuting WANG, Jianing SHI, Dan YU, Renhua YANG, Zhiqiang SHEN, Jiang LONG, Peng CHEN. Network Pharmacology-based Analysis of the Anti-atherosclerosis Mechanism of Scutellarin and Experimental Validation in Vivo. Journal of Kunming Medical University, 2022, 43(8): 17-27. doi: 10.12259/j.issn.2095-610X.S20220804
[4]	Yanlong LIU, Xuefeng GUANG, Xiaolong YIN, Hailong DAI. Effects of miR-125a-3p on Atherosclerotic Plaque, M1/M2 Macrophages, MMP-9 and VEGF. Journal of Kunming Medical University, 2022, 43(9): 1-6. doi: 10.12259/j.issn.2095-610X.S20220915
[5]	Li ZHANG, Dan YU, Yu-ting WANG, Zhi-mei GOU, Ren-hua YANG, Bo HE, Zhi-qiang SHEN, Wen-ying CHAI, Peng CHEN. Effects of Scutellarin on Expressions of PKC and TNF-α in OX-LDL Injured RAW264.7 Cells in vitro. Journal of Kunming Medical University, 2021, 42(10): 1-7. doi: 10.12259/j.issn.2095-610X.S20211040
[6]	Hai-long DAI, Nan WANG, Xiao-qing CHEN, Zhen-yi HE, Xiao-lan FENG, Xue-feng GUANG. Characteristics of Intestinal Microflora in Patients with Coronary Heart Disease. Journal of Kunming Medical University, 2020, 41(12): 36-41. doi: 10.12259/j.issn.2095-610X.S20201213
[7]	Zhang Xiao Chao , Shen Zhi Qiang , Yang Ren Hua , Tang Chuan Jing , Bai Lin Ying , He Bo , Chen Peng , Yao Rong Cheng . Effects of Corilagin on Expression of CRP in OX-LDL Injured Macrophage Cells. Journal of Kunming Medical University, 2017, 38(08): 1-5.
[8]	Huang Sheng Hua , Li Xiao Xia , Lian Xi Yan , Chen Zi Yao , Zhao Jing Tao , Feng Zhi Jian . Influence of Uric Acid on Human Umbillical Vein Endothelial Cells under Oxidative Stress. Journal of Kunming Medical University, 2016, 37(12): 20-23.
[9]	Ke Ting Yu . . Journal of Kunming Medical University,
[10]	Lan Dan Feng . . Journal of Kunming Medical University,
[11]	Cao Rui . . Journal of Kunming Medical University,
[12]	Guan Bing . . Journal of Kunming Medical University,
[13]	Chen Li Ling . . Journal of Kunming Medical University,
[14]	Hu Yan Jie . . Journal of Kunming Medical University,
[15]	Nie Zhi . . Journal of Kunming Medical University,
[16]	Wang Ling . The Correlation between Lower Extremity Atherosclerosis and Bone Mineral Density in Type 2 Diabetes Mellitus Patients. Journal of Kunming Medical University,
[17]	. Therapeutic Effect of PAS Combination Therapy on 40 Patients with Atherosclerosis. Journal of Kunming Medical University,
[18]	. Evaluation of Atherosclerosis in Rheumatoid Arthritis Patients with High Lipid Levels by Ultrasonography. Journal of Kunming Medical University,
[19]	Deng Zi Yu . . Journal of Kunming Medical University,
[20]	Qiu Hong Mei . . Journal of Kunming Medical University,